Range
4.33 - 6.74
Vol / Avg.
10.8M/3.2M
Div / Yield
-
52 Wk
4.3 - 33.55
Mkt Cap
445.3M
Payout Ratio
-
Open
4.42
P/E
-
Shares
85.3M
Outstanding
85.3M
Total Float
27.9M
load more
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders. Its pipeline of product candidates consist of two novel therapeutic drug candidates namely AL001 a patented ionic co-crystal technology delivering a therapeutic combination of lithium, proline and salicylate, and; AL002 a patented method using a mutant peptide sensitized cell as a cell-based therapeutic vaccine that reduces beta-amyloid plaque and seeks to restore the ability of the patient's immunological system to combat Alzheimer's.

Earnings

see more
Q2 2021Est.ActualSurprise
EPS
(EXPECTED)2021-08-23
REV

Related Companies

TickerCompanyChg %Mkt Cap
ALZNAlzamend Neuro1.53%445.3M

Alzamend Neuro Frequently Asked Questions

Q

How do I buy Alzamend Neuro (ALZN) stock?

A

You can purchase shares of Alzamend Neuro (NASDAQ: ALZN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Alzamend Neuro's (ALZN) competitors?

A

There are no as such competitors for Alzamend Neuro.

Q

What is the target price for Alzamend Neuro (ALZN) stock?

A

There is no analysis for Alzamend Neuro

Q

Current Stock Price for Alzamend Neuro (ALZN)?

A

The stock price for Alzamend Neuro (NASDAQ: ALZN) is $5.22 last updated Today at 8:00:01 PM.

Q

Does Alzamend Neuro (ALZN) pay a dividend?

A

There are no upcoming dividends for Alzamend Neuro.

Q

When is Alzamend Neuro (NASDAQ:ALZN) reporting earnings?

A
Alzamend Neuro’s Q2 earnings are confirmed for after-market on August 23, 2021.
Q

Is Alzamend Neuro (ALZN) going to split?

A

There is no upcoming split for Alzamend Neuro.

Q

What sector and industry does Alzamend Neuro (ALZN) operate in?

A

Alzamend Neuro is in the Consumer Discretionary sector and Multiline Retail industry. They are listed on the NASDAQ.